Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II
- Status
- NOT_YET_RECRUITING
- Phase
- NA
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study to Learn More About Tukysa Once it is Out in the Korean Market
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
- Status
- RECRUITING
- Phase
- NA
Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE4